Stellate Ganglion Block Versus Oral Medication in Treatment of Palmar Hyperhidrosis

NCT06731101 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-02-06

No results posted yet for this study

Summary

The aim of the study is to compare between ganglion block versus combined oral anticholinergic and antidepressant drugs on treatment of palmar hyperhidrosis

Conditions

  • Palmar Hyperhidrosis

Interventions

DRUG

Bupivacaine + Lidocaine +dexamethasone

Sonar guided block of Stellate Ganglion By Bupivacaine + Lidocaine

DRUG

Tryptizole + Librax

Tryptizole + Librax

Sponsors & Collaborators

  • Fayoum University

    lead OTHER

Principal Investigators

  • Atef M Khalil, professor · Fayoum University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-15
Primary Completion
2025-12-10
Completion
2026-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06731101 on ClinicalTrials.gov